2024 ESC Guidelines for the management of peripheral arterial and aortic diseases: Developed by the task force on the management of peripheral arterial and aortic …

L Mazzolai, G Teixido-Tura, S Lanzi, V Boc… - European heart …, 2024 - academic.oup.com
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Epidemiology and management of aortic disease: aortic aneurysms and acute aortic syndromes

E Bossone, KA Eagle - Nature Reviews Cardiology, 2021 - nature.com
The aorta is the 'greatest artery', through which oxygenated blood is delivered from the left
ventricle to end organs with each cardiac cycle (200 million litres of blood transported in an …

2022 ACC/AHA guideline for the diagnosis and management of aortic disease: a report of the American Heart Association/American College of Cardiology Joint …

Writing Committee Members, EM Isselbacher… - Journal of the American …, 2022 - jacc.org
Abstract Aim The “2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic
Disease” provides recommendations to guide clinicians in the diagnosis, genetic evaluation …

[HTML][HTML] Clinical relevance of genotype–phenotype correlations beyond vascular events in a cohort study of 1500 Marfan syndrome patients with FBN1 pathogenic …

P Arnaud, O Milleron, N Hanna, J Ropers, NO Ouali… - Genetics in …, 2021 - Elsevier
Purpose Marfan syndrome (MFS) is a connective tissue disorder in which several systems
are affected with great phenotypic variability. Although known to be associated with …

Multimodality imaging in thoracic aortic diseases: a clinical consensus statement from the European Association of Cardiovascular Imaging and the European Society …

A Evangelista, M Sitges, G Jondeau… - European Heart …, 2023 - academic.oup.com
Imaging techniques play a pivotal role in the diagnosis, follow-up, and management of aortic
diseases. Multimodality imaging provides complementary and essential information for this …

EACTS/STS Guidelines for diagnosing and treating acute and chronic syndromes of the aortic organ

M Czerny, M Grabenwöger, T Berger… - European Journal of …, 2024 - academic.oup.com
These guidelines, endorsed by both the EACTS and STS, represent the official viewpoint on
this topic. They show a commitment to ongoing improvement, as regular updates will be …

[HTML][HTML] 2022 ACC/AHA guideline for the diagnosis and management of aortic disease: a report of the American heart association/American college of cardiology joint …

WC Members, EM Isselbacher, O Preventza… - Journal of the American …, 2022 - Elsevier
Abstract Aim The “2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic
Disease” provides recommendations to guide clinicians in the diagnosis, genetic evaluation …

Cardiogenetics: genetic testing in the diagnosis and management of patients with aortic disease

PD Thakker, AC Braverman - Heart, 2021 - heart.bmj.com
Thoracic aortic aneurysm and aortic dissection have a potent genetic underpinning with
20% of individuals having an affected relative. Heritable thoracic aortic diseases (HTAD) …

[HTML][HTML] MINOCA biomarkers: Non-atherosclerotic aspects

X Xu, G Zhang, Z Li, D Li, R Chen, C Huang, Y Li… - Clinica Chimica …, 2023 - Elsevier
Myocardial infarction in the absence of obstructive coronary artery disease (MINOCA) is an
important subtype of myocardial infarction. Although comprising less than 50% stenosis in …

The extracellular matrix glycoprotein fibrillin-1 in health and disease

L Li, J Huang, Y Liu - Frontiers in Cell and Developmental Biology, 2024 - frontiersin.org
Fibrillin-1 (FBN1) is a large, cysteine-rich, calcium binding extracellular matrix glycoprotein
encoded by FBN1 gene. It serves as a structural component of microfibrils and provides …